BNTC - Benitec Biopharma Ltd ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BNTC is currently covered by 3 analysts with an average price target of $27. This is a potential upside of $23.02 (174.67%) from yesterday's end of day stock price of $9.83.

Benitec Biopharma Ltd ADR's activity chart (see below) currently has 28 price targets and 34 ratings on display. The stock rating distribution of BNTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 14.74% with an average time for these price targets to be met of 26.58 days.

Highest price target for BNTC is $32, Lowest price target is $22, average price target is $27.

Most recent stock forecast was given by from GUGGENHEIM on 10-Jun-2026. First documented stock forecast 20-Apr-2020.

Currently out of the existing stock ratings of BNTC, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Sep-2024

$17

3 months 13 days ago
(10-Jun-2026)

0/2 (0%)

$7 (70.00%)

Buy Since 21-Feb-2025

$32

$19.63 (158.69%)

$32

6 months 14 days ago
(09-Mar-2026)

0/7 (0%)

$19.45 (154.98%)

Buy Since 18-Oct-2022

$22

$9.63 (77.85%)

$20

10 months 19 days ago
(04-Nov-2025)

5/13 (38.46%)

$6.29 (40.04%)

159

Buy Since 16-Oct-2024

$29

$16.63 (134.44%)

$35

1 years 7 days ago
(16-Sep-2025)

0/2 (0%)

$15.08 (108.33%)

Buy Since 13-Jun-2024

$30

$17.63 (142.52%)

$30

1 years 10 months 8 days ago
(15-Nov-2024)

0/5 (0%)

$19.32 (180.90%)

Show more analysts

Please expand the browser size to see the chart

What is BNTC (Benitec Biopharma Ltd ADR) average time for price targets to be met?

On average it took 27 days for the stock forecasts to be reached, with an average price target met ratio of 14.74%.

Which analyst most recently updated their price target on BNTC (Benitec Biopharma Ltd ADR)?

Which analyst has the most public recommendations on BNTC (Benitec Biopharma Ltd ADR)?

has 0 price targets and 0 ratings on BNTC

Which analyst is the currently most bullish on BNTC (Benitec Biopharma Ltd ADR)?

Raghuram Selvaraju with the highest potential upside of $20.98

Which analyst is the currently most reserved on BNTC (Benitec Biopharma Ltd ADR)?

Patrick Trucchio with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?